Phase I clinical trial on intracoronary administration of Ad-hHGF treating severe coronary artery disease
about
Novel therapy for myocardial infarction: can HGF/Met be beneficial?Interleukin-7 and Immunosenescence.Catheter-based intramyocardial delivery (NavX) of adenovirus achieves safe and accurate gene transfer in pigs.Gene therapy using hepatocyte growth factor expressing adenovirus improves skin flap survival in a rat model.Protein kinase G1 α overexpression increases stem cell survival and cardiac function after myocardial infarction.Long-term follow-up assessment of a phase 1 trial of angiogenic gene therapy using direct intramyocardial administration of an adenoviral vector expressing the VEGF121 cDNA for the treatment of diffuse coronary artery disease.HGF percutaneous endocardial injection induces cardiomyocyte proliferation and rescues cardiac function in pigs.Targeting Motor End Plates for Delivery of Adenoviruses: An Approach to Maximize Uptake and Transduction of Spinal Cord Motor Neurons.Gene therapy to treat cardiovascular disease.Gene delivery methods in cardiac gene therapy.Percutaneous approaches for efficient cardiac gene delivery.Gene therapy for heart disease: molecular targets, vectors and modes of delivery to myocardium.Gene therapy research in Asia.Cardiovascular Gene Therapy: Past, Present, and Future.Pigment epithelium-derived factor plays an inhibitory role in proliferation and migration of HaCaT cells.Angiogenic gene therapy in cardiovascular diseases: dream or vision?One hundred years of myocardial infarction.Hepatocyte Growth Factor Isoforms in Tissue Repair, Cancer, and Fibrotic Remodeling.
P2860
Q28305555-BA5F0C5A-565C-4FD3-8548-99C23DA7A0D9Q33582101-6F63A456-153C-4589-A85C-F63DCC64A9E3Q34542255-25342960-3295-41B4-9FED-E12480AAD618Q34588837-62ACA3CF-AF99-4B0F-9BC9-4AFC530C3D24Q34639920-3B643CE7-AD86-466E-B192-F1A224ECC7B1Q36634798-EB67E1F0-ED2B-41BA-BBB0-D7770CCDDB2EQ36681433-9C7556F3-4080-4BEA-9ADD-02FF866BE3D2Q37251346-7601624A-AA29-4A54-8152-696C43784111Q37310450-007C4CF4-077F-421C-954B-B5680547CCD6Q37939775-EEC3E6A5-A6E9-4AC1-89D2-306C86008697Q38113171-BE4A5AFC-D5F6-48B5-B14D-0FFD0F3EDB56Q38132253-10ED685D-6149-4676-9DEA-C8324E9140CCQ38654544-38A16EFB-BF78-40BE-AE60-A3F4A05F0060Q38733395-719A05B7-2948-4E6C-881F-B5D3BE56E296Q39653387-8CE1FE73-C8AC-435B-86C8-83F69BD02012Q45863499-9A624F74-1828-435C-8E64-7568AAAE8A16Q48344135-93675860-862C-4E47-BD59-8B2C02700DA8Q50977853-2E8AD1EF-32F6-4FA7-A882-87176E10A629
P2860
Phase I clinical trial on intracoronary administration of Ad-hHGF treating severe coronary artery disease
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Phase I clinical trial on intr ...... severe coronary artery disease
@ast
Phase I clinical trial on intr ...... severe coronary artery disease
@en
Phase I clinical trial on intr ...... severe coronary artery disease
@nl
type
label
Phase I clinical trial on intr ...... severe coronary artery disease
@ast
Phase I clinical trial on intr ...... severe coronary artery disease
@en
Phase I clinical trial on intr ...... severe coronary artery disease
@nl
prefLabel
Phase I clinical trial on intr ...... severe coronary artery disease
@ast
Phase I clinical trial on intr ...... severe coronary artery disease
@en
Phase I clinical trial on intr ...... severe coronary artery disease
@nl
P2093
P3181
P1476
Phase I clinical trial on intr ...... severe coronary artery disease
@en
P2093
Chu-Tse Wu
Chun-Jian Li
En-Zhi Jia
Ke-Jiang Cao
Li-Sheng Wang
Lian-Sheng Wang
P2888
P304
P3181
P356
10.1007/S11033-008-9315-3
P407
P577
2009-07-01T00:00:00Z
P6179
1022078814